Pectopexy for Apical Prolapse Management
Pectopexy for Treatment of Apical Pelvic Organ Prolapse
1 other identifier
interventional
10
1 country
1
Brief Summary
This study was designed to evaluate the efficacy of pectopexy for treatment of apical pelvic organ prolapse at follow up at 12 months. Investigator also evaluates complications, improvement of symptoms, quality-of-life outcomes and patient satisfaction with surgery. Assessment of restoration of normal pelvic anatomy and lower urinary tract symptoms using transperineal ultrasound
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started May 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 24, 2024
CompletedFirst Posted
Study publicly available on registry
April 17, 2024
CompletedStudy Start
First participant enrolled
May 9, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2025
CompletedMay 10, 2024
May 1, 2024
9 months
March 24, 2024
May 9, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Pelvic Organ Prolapse Quantification stage
Stage 0 to stage 4
6 , 12 months
Secondary Outcomes (2)
Urinary Symptoms questionnaire
6 , 12 months months
Bladder neck measurements using Transperineal US
6 , 12 months
Study Arms (1)
Pectopexy
EXPERIMENTALAll operations will be performed with patient in loyd davies position, sterilization of the perineum then sterilization of the vagina. Evacuation of the bladder and examination under anesthesia is done. Skin incision through pfannenstiel one then incision of subcutaneous tissue, rectus sheath, separation of recti muscle and opening of parietal peritoneum. A polypropylene mesh (30×30 cm, Ethicon, Inc., Somerville, NJ) is cut to obtain two long arms (15-20 cm long) and a rectangular piece (4-7 cm wide). The mesh is fashioned and fixed over the dissected uterine isthmus and anterior part of the cervix with separated number 1 Prolene and number 1 Vicryl sutures. Peritoneal incision was made from the right round ligament toward the pelvic side wall . The mesh arm is grasped and laterally pulled out So the rectangular part of the mesh will be on the anterior part of the cervix The mesh arms are suspended and sutured to Pectineal liga peritoneum is closed over the mesh
Interventions
Eligibility Criteria
You may qualify if:
- Apical prolapse Stage 2-4 acc. to POP-Q system
- Uterine preservation or after hysterectomy
- Age \> 18 years old.
- Sexually active or not.
You may not qualify if:
- Pregnancy or up to 6 months postpartum.
- Current Urinary tract infection proved by urine analysis or urine culture.
- Patient unfit for surgery.
- Previous suspension operations.
- Uncontrolled diabetic patients
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Women Health Hospital
Asyut, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Lecturer of Obs& Gyn. Specialist of Urogynecology
Study Record Dates
First Submitted
March 24, 2024
First Posted
April 17, 2024
Study Start
May 9, 2024
Primary Completion
February 1, 2025
Study Completion
August 1, 2025
Last Updated
May 10, 2024
Record last verified: 2024-05